FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/01/016963 [Registered on: 08/01/2019] Trial Registered Prospectively
Last Modified On: 01/01/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   AYURVEDIC MANAGEMENT OF CERVICAL SPONDYLOSIS 
Scientific Title of Study   EFFICACY OF VAJIGANDHADI YOGA AND SVALPAMASHA TAILA NASYA IN THE MANAGEMENT OF CERVICAL SPONDYLOSIS W.S.R. TO MANYASTAMBHA: AN OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAL 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Appurva Sharma 
Designation  MD AYU Scholar Department of Kayachikitsa 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  IPGT and RA GUJARAT AYURVED UNIVERSITY Near GGH hospital Jamnagar
4th floor Department of Kayachikitsa New building IPGT and RA GUJARAT AYURVED UNIVERSITY Jamnagar
Jamnagar
GUJARAT
361008
India 
Phone  9780914411  
Fax    
Email  appurva.appu@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Alankruta R Dave 
Designation  Associate Professor Department of Kayachikitsa 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  4th floor Department of Kayachikitsa New building IPGT and RA GUJARAT AYURVED UNIVERSITY Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  9824171817  
Fax    
Email  alankruta@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  APPURVA SHARMA 
Designation  MD AYU Scholar Department of Kayachikitsa 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  Department of Kayachikitsa New building IPGT and RA GUJARAT AYURVED UNIVERSITY Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  9780914411  
Fax    
Email  appurva.appu@gmail.com  
 
Source of Monetary or Material Support  
IPGT and RA GUJARAT AYURVED UNIVERSITY Jamnagar GUJRAT 361008 
 
Primary Sponsor  
Name  Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar 
Address  IPGT and RA GUJARAT AYURVED UNIVERSITY Near GGH Hospital Jamnagar 361008 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Appurva Sharma  Institute for Post Graduate Teaching and Research in Ayurveda  Department of kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar
Jamnagar
GUJARAT 
9780914411

appurva.appu@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M478||Other spondylosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A  Group A- Vajigandhadi Yoga two tab(500mg) thrice a day after meals 
Comparator Agent  Group B  Group B- Nasya with Svalpmasha tail 4ml each nostril once a day + Vajigandhadi Yoga 2tab(500mg) thrice a day after meals  
 
Inclusion Criteria  
Age From  20.00 Day(s)
Age To  65.00 Day(s)
Gender  Both 
Details  1 Patients having signs and symptoms of Cervical Spondylosis
2 X-ray of cervical spine showing relevant changes of Cervical Spondylosis like narrowing of joint space and osteophytes at the vertebral margins
3 Patient between age of 20-65 of either sex and willing to give their consent to participate in the study
 
 
ExclusionCriteria 
Details  1 patients below the age of 20 and above 65
2 Patient having associated conditions like fibrositis, rheumatoid spondylitis, ankylosing spondylitis
3 Pregnancy, Lactation
4 TB of cervical spine
5 Nasal polyps
6 Active Malignant disease.
7 Uncontrolled Diabetes Mellitus, Uncontrolled Hypertension
8 Pakshaghat, Avbahuka, Khanja
9 Complication of Cervical spondylosis (like paraplegia, bladder and bowel involvement)
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
management of pain and improvement in other sign and symptom of cervical spondylosis  8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
improve quality of life of patients of cervical spondylosis  8 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   28/01/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is the randomized clinical trial to evaluate the effect of Vajigandhadi Yoga and Svalpmasha tail  nasya in the managment of Cervical Spondylosis(Manyastambha). Total 30 patient will be enrolled in present study. Selected patient will be divided in two groups on the basis of computer generated randomisation method. In this study Group A will be given Vajigandhadi Yoga in dose of 2 tablet(500mg each) TDS after meals with normal water for 8 weeks. In Group B same dose of  Vjigandhadi yoga will be administer along with 3 sitting Svalpmasha tail in the dose of 4ml each nostril at morning once in a day for 7 days with the interval of 7 days. Follow up will be carried out at every week for the interval of one month.  
Close